Sordahl L A, LaBelle E F, Rex K A
Am J Physiol. 1984 Jan;246(1 Pt 1):C172-6. doi: 10.1152/ajpcell.1984.246.1.C172.
Amiloride, a K+-sparing diuretic, and diltiazem, a Ca2+ channel antagonist, have both been reported to inhibit Na+ transport-associated processes in different subcellular membrane systems. In this report, similar inhibitory effects of both agents are demonstrated on Na+-induced Ca2+ release from rabbit heart mitochondria and on Na+ uptake in a kidney medulla microsomal preparation. Both amiloride and diltiazem produce 50% inhibition of Na+ uptake in kidney microsomes at the same concentrations. Heart mitochondrial Na+-induced Ca2+ release was 50% inhibited by 6 microM diltiazem and 200 microM amiloride. No effects of either agent on mitochondrial respiratory activity were observed. The results suggest a specific effect of both drugs on a Na+-binding site associated with an antiport exchange process. These data also extend previous observations suggesting the use of these agents as tools to define further ion transport mechanisms in biological membranes.
氨氯地平(一种保钾利尿剂)和地尔硫䓬(一种钙通道拮抗剂)均已被报道可抑制不同亚细胞膜系统中与钠转运相关的过程。在本报告中,这两种药物对兔心脏线粒体钠诱导的钙释放以及肾髓质微粒体制剂中的钠摄取均表现出相似的抑制作用。氨氯地平和地尔硫䓬在相同浓度下均可使肾微粒体中的钠摄取受到50%的抑制。6微摩尔的地尔硫䓬和200微摩尔的氨氯地平可使心脏线粒体钠诱导的钙释放受到50%的抑制。未观察到这两种药物对线粒体呼吸活性有任何影响。结果表明这两种药物对与反向转运交换过程相关的钠结合位点具有特异性作用。这些数据还扩展了先前的观察结果,提示可将这些药物用作工具来进一步确定生物膜中的离子转运机制。